MYCN and neuroblastoma: We treated NBL-W-S NB cell lines (MYCN amplified) and SK-N-AS NB cell lines (MYCN non-amplified) with GANT 61 to evaluate changes in PERK- eIF2α-ATF4 pathway induction levels.